Etodolac (CAS 41340-25-4)

Etodolac is a nonsteroidal anti-inflammatory compound that functions as an inhibitor of the enzyme cyclooxygenase (COX). It specifically inhibits the COX-2 enzyme, which is responsible for the production of prostaglandins involved in inflammation and pain. By blocking the action of COX-2, etodolac reduces the synthesis of prostaglandins, thereby decreasing inflammation and pain. This chemical′s mode of action involves binding to the active site of the COX-2 enzyme, preventing the conversion of arachidonic acid into prostaglandins. This inhibition of prostaglandin synthesis contributes to the anti-inflammatory and analgesic effects of etodolac. Additionally, etodolac may act to have some selectivity for COX-2 over COX-1, which may contribute to its reduced gastrointestinal side effects compared to other NSAIDs. Overall, etodolac′s function as a COX-2 inhibitor makes it a useful tool for studying the role of prostaglandins in inflammation and pain pathways at the molecular level.